Loading clinical trials...
Loading clinical trials...
Randomized, Multicenter Study to Compare the Efficacy of Pegylated Interferon Alfa (PEG-IFN) in Combination With Two Different Doses of Ribavirin in Patients With Chronic Hepatitis C and Subtype 2/3
Conditions
Interventions
peginterferon alfa-2a [Pegasys]
peginterferon alfa-2a [Pegasys]
+2 more
Locations
18
Austria
Gratwein, Austria
Graz, Austria
Innsbruck, Austria
Linz, Austria
Linz, Austria
Oberndorf, Austria
Start Date
May 1, 2003
Primary Completion Date
July 1, 2008
Completion Date
July 1, 2008
Last Updated
July 11, 2016
NCT05870969
NCT03987503
NCT04382404
NCT01226797
NCT00062816
NCT04774107
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions